Incidence of Lyme borreliosis in the Würzburg region of Germany
- PMID: 10584895
- DOI: 10.1007/s100960050381
Incidence of Lyme borreliosis in the Würzburg region of Germany
Abstract
To assess the incidence of Lyme borreliosis in Central Europe, a 12-month, prospective, population-based surveillance study of Lyme borreliosis was conducted in the Wurzburg region of central Germany, following an aggressive awareness campaign. The diagnosis of Lyme borreliosis required the presence of (i) erythema migrans (diameter > or =5 cm); (ii) lymphocytoma; or (iii) another specific manifestation including Lyme arthritis, neuroborreliosis, carditis or acrodermatitis chronica atrophicans in conjunction with serological confirmation. A total of 313 cases of Lyme borreliosis was diagnosed, giving an incidence of 111 cases/100000 inhabitants, the highest rates occurring in children and elderly adults living in wooded as opposed to agricultural areas. The incidence in city dwellers and inhabitants of rural areas was not significantly different. Erythema migrans was the only manifestation in 279 (89%) patients. Of the 34 patients with manifestations other than erythema migrans alone, 15 had arthritis, nine neuroborreliosis, six lymphocytoma, four acrodermatitis chronica atrophicans and one carditis. Children were more likely than adults to have manifestations other than erythema migrans alone. Lyme borreliosis was very common in central Germany, and one of the most frequent bacterial infections. The observation of more cases of arthritis than neuroborreliosis was similar to that in the USA. These results may be representative for many parts of central Europe and suggest the need for development of a vaccine against borreliosis caused by European strains of Borrelia species.
Similar articles
-
Isolation of Borrelia burgdorferi sensu lato from blood of adult patients with borrelial lymphocytoma, Lyme neuroborreliosis, Lyme arthritis and acrodermatitis chronica atrophicans.Infection. 2011 Feb;39(1):35-40. doi: 10.1007/s15010-010-0062-8. Epub 2010 Dec 10. Infection. 2011. PMID: 21153429
-
Clinical and epidemiological features of Lyme borreliosis in Bulgaria.Wien Klin Wochenschr. 2004 Jan 31;116(1-2):42-6. doi: 10.1007/BF03040423. Wien Klin Wochenschr. 2004. PMID: 15030123
-
[Lyme Borreliosis: Cutaneous and Neurologic Manifestations, Case Definitions and Therapy].Dtsch Med Wochenschr. 2020 Jan;145(1):19-28. doi: 10.1055/a-0793-4513. Epub 2020 Jan 8. Dtsch Med Wochenschr. 2020. PMID: 31914465 German.
-
Skin manifestations of lyme borreliosis: diagnosis and management.Am J Clin Dermatol. 2008;9(6):355-68. doi: 10.2165/0128071-200809060-00002. Am J Clin Dermatol. 2008. PMID: 18973402 Review.
-
Lyme borreliosis.Lancet Infect Dis. 2003 Aug;3(8):489-500. doi: 10.1016/s1473-3099(03)00722-9. Lancet Infect Dis. 2003. PMID: 12901891 Review.
Cited by
-
Cutaneous Lyme borreliosis: Guideline of the German Dermatology Society.Ger Med Sci. 2017 Sep 5;15:Doc14. doi: 10.3205/000255. eCollection 2017. Ger Med Sci. 2017. PMID: 28943834 Free PMC article.
-
Physician reported incidence of early and late Lyme borreliosis.Parasit Vectors. 2015 Mar 15;8:161. doi: 10.1186/s13071-015-0777-6. Parasit Vectors. 2015. PMID: 25889086 Free PMC article.
-
[Lyme borreliosis].Z Rheumatol. 2009 May;68(3):239-52; quiz 253-4. doi: 10.1007/s00393-009-0460-4. Z Rheumatol. 2009. PMID: 19387665 German.
-
Efficacy and Safety of Antibiotic Therapy in Early Cutaneous Lyme Borreliosis: A Network Meta-analysis.JAMA Dermatol. 2018 Nov 1;154(11):1292-1303. doi: 10.1001/jamadermatol.2018.3186. JAMA Dermatol. 2018. PMID: 30285069 Free PMC article. Review.
-
[Neuroborreliosis - Diagnostics, treatment and course].Nervenarzt. 2017 Apr;88(4):419-431. doi: 10.1007/s00115-016-0263-1. Nervenarzt. 2017. PMID: 28175945 German.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical